×

Role of surgical therapy in the management of gestational trophoblastic neoplasia
Obstetrics & Gynecology Science 58/4 :277-283,2015

Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim’s technique and comparison to laparotomy
Obstetrics & Gynecology Science 60/2 :178-186,2017

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
JOURNAL OF GYNECOLOGIC ONCOLOGY 28/6 :e73-,2017

Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models.
CANCER RESEARCH AND TREATMENT 50/3 :956-963,2018

Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center
JOURNAL OF GYNECOLOGIC ONCOLOGY 29/4 :e63-e73,2018

Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY 25/5 :823-831,2018

Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.
PLOS ONE 13/9 :203,366-203,376,2018

Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer
GYNECOLOGIC ONCOLOGY 148/1 :62-67,2018

In-bag power morcellation technique in single-port laparoscopic myomectomy
Obstetrics & Gynecology Science 61/2 :267-273,2018

Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer
Obstetrics & Gynecology Science 61/2 :227-234,2018

Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience
YONSEI MEDICAL JOURNAL 59/8 :930-936,2018

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced?stage ovarian cancer
CANCER MEDICINE 8/2 :564-571,2019

Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
EJSO 45/4 :644-649,2019

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)
BMC CANCER 19/1 :e341-,2019